Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

5.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Staging of non-metastatic nasopharyngeal carcinoma with PET/CT.

European radiology·2026
Same author

Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort study.

The Lancet. Oncology·2026
Same author

HER2-low and HER2-ultra-low salivary gland carcinomas: an exploratory study.

Virchows Archiv : an international journal of pathology·2026
Same author

Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Intensity-modulated proton therapy vs intensity-modulated radiotherapy in nasopharyngeal carcinoma: a case-control study.

Lancet regional health. Americas·2026
Same author

Head and Neck Cancer: A Review.

JAMA·2025
Same journal

Measuring Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

A Virtual Reality Psychosocial Intervention for Patients Undergoing Bone Marrow Transplantation (BMT-VR): Pilot Randomized Clinical Trial.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Nationwide Trends in Colorectal Cancer Screening by the End of the COVID-19 Pandemic: Racial/Ethnic Differences and Opportunities.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Evaluation of the Impact of Adjuvant Immunotherapy in Merkel Cell Carcinoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Payers' Views on Insurance Coverage for Confirmatory Diagnostics After a Noncovered Multicancer Early Detection (MCED) Test.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
See all related articles

Related Experiment Video

Updated: May 2, 2026

Merkel Cell Polyomavirus Infection and Detection
13:45

Merkel Cell Polyomavirus Infection and Detection

Published on: February 7, 2019

9.6K

Merkel cell carcinoma, version 1.2014.

Christopher K Bichakjian, Thomas Olencki, Murad Alam

    Journal of the National Comprehensive Cancer Network : JNCCN
    |March 12, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Merkel cell carcinoma, a rare skin cancer, has high recurrence and metastasis rates. Updated NCCN guidelines offer improved diagnosis and management strategies, including new pathology and imaging recommendations.

    More Related Videos

    A 3D Organotypic Melanoma Spheroid Skin Model
    08:49

    A 3D Organotypic Melanoma Spheroid Skin Model

    Published on: May 18, 2018

    18.1K
    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
    07:41

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

    Published on: March 8, 2022

    2.3K

    Related Experiment Videos

    Last Updated: May 2, 2026

    Merkel Cell Polyomavirus Infection and Detection
    13:45

    Merkel Cell Polyomavirus Infection and Detection

    Published on: February 7, 2019

    9.6K
    A 3D Organotypic Melanoma Spheroid Skin Model
    08:49

    A 3D Organotypic Melanoma Spheroid Skin Model

    Published on: May 18, 2018

    18.1K
    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
    07:41

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

    Published on: March 8, 2022

    2.3K

    Area of Science:

    • Oncology
    • Dermatology

    Background:

    • Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer.
    • MCC exhibits high rates of local recurrence and distant metastasis, similar to nonmelanoma skin cancers and thick melanoma, respectively.

    Purpose of the Study:

    • To provide updated clinical evidence and expert consensus for the diagnosis and management of Merkel cell carcinoma.
    • To incorporate revisions on PET/CT imaging and pathology principles into clinical guidelines.

    Main Methods:

    • Review of clinical evidence and expert consensus.
    • Inclusion of updated recommendations for diagnostic imaging (PET/CT).
    • Addition of a new section detailing principles of pathology for MCC analysis and reporting.

    Main Results:

    • Revised guidelines for Merkel cell carcinoma diagnosis and management.
    • Specific recommendations on the utility and application of PET/CT imaging.
    • Guidance on pathology analysis, interpretation, and reporting for MCC.

    Conclusions:

    • The updated NCCN Guidelines offer a comprehensive framework for managing Merkel cell carcinoma.
    • Emphasis on advanced imaging and detailed pathology improves diagnostic accuracy and treatment planning for this aggressive skin cancer.